Additionally, active HER2 targeting was evaluated in a SKOV-3 xenograft mouse model, demonstrating an accumulation of EVs in the tumour tissue and indicating the potential use of radioactive nanoparticles in tumour imaging or treatment. Here, ERBB2 is linked to neoplasm.